Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03103711
Other study ID # ONCOTIC-I
Secondary ID
Status Completed
Phase N/A
First received March 21, 2017
Last updated March 31, 2017
Start date July 2010
Est. completion date December 2011

Study information

Verified date March 2017
Source University of Valencia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to analyze the effect of a brief psychological intervention supported by Information and Communication Technologies, on the subjective well-being of hospitalized cancer patients. Participants are randomly assigned to one of 2 conditions: Intervention condition (4 Virtual reality sessions) and Control condition (waiting list control group).


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adults with any cancer diagnosis

- hospitalized for at least 1 week

- Karnofsky functional state =50

- life expectancy =2 months

Exclusion Criteria:

- serious psychopathology

- cognitive impairment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Virtual Reality Intervention
Participants receive two sessions oriented to joy and two focused on relax. In the first 2 sessions patients can choose the environment ("Emotional Parks" or "Walk through Nature") and in the following ones participants visit the alternate environments.

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
University of Valencia Hospital Clínica Benidorm, Universidad Politécnica de Valencia, Universitat Jaume I

Outcome

Type Measure Description Time frame Safety issue
Other The Brief Illness Perception Questionnaire (BIPQ) (Broadbent et al., 2006) This instrument has 9 items aimed to evaluate the cognitive and emotional representation of the illness (consequences, timeline, personal control, treatment control, identity, concern, emotional response, illness coherence and causes). baseline
Other Personal meaning of the illness (ad-hoc). Patient has 6 alternatives of illness meaning (Loss, threat, challenge, blame-others, blame-self and opportunity). In addition to these alternatives, participant can add any other personal meaning. baseline
Other Visual Analog Scale: Optimism 11-point scale (not at all - completely) baseline
Other Visual Analog Scale: Life satisfaction 7-point scale (no satisfaction - completely satisfied) baseline
Primary The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983; adapted version of Tejero, Guimerá, Farré & Peri, 1986) change from baseline at 1 week
Primary Fordyce Happiness Scale (Fordyce, 1988). change from baseline at 1 week
Secondary Visual Analog Scale: Mood. Subjective mood change after each intervention session. 4 days along 1 week
Secondary Visual Analog Scale: Emotional State. Change from pre to post session. Assessment of general mood, joy, sadness, anxiety, relax and vigor (7-point Likert scale) 4 days along 1 week
Secondary Visual Analog Scale: Physical Discomfort. Change from pre to post session. Presence of pain, fatigue and physical discomfort (11-point Likert scale) 4 days along 1 week
Secondary Visual Analog Scale: Satisfaction with the Session Scale. Level of pleasantness and perceived usefulness of each session (11-point Likert scale) 4 days along 1 week
Secondary Satisfaction with Intervention Scale (adapted version of Borkovec and Nau's, 1972) Assesses satisfaction, recommendation, utility and discomfort (11-point Likert scale) 1 week
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases